Screener
Travere Therapeutics, Inc. TVTX Price / book
Price / book at other companies
Other financials
Where this comes from
Calculated from Travere Therapeutics, Inc.’s reported figures.
Based on the most recent quarter.
The source filing: Travere Therapeutics, Inc.’s 10-Q, filed May 4, 2026. Open the filing →
- Filed
- May 4, 2026, 4:45 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001438533-26-000042
FAQ
- What is Travere Therapeutics, Inc.'s price / book?
- Travere Therapeutics, Inc. (TVTX) reported price / book of 27.8× in Q1 2026.
- How has Travere Therapeutics, Inc.'s price / book changed year-over-year?
- Travere Therapeutics, Inc.'s price / book decreased by 42.7% year-over-year, from 48.4× to 27.8×.
- What is the long-term trend for Travere Therapeutics, Inc.'s price / book?
- Over 5 years (2020 to 2025), Travere Therapeutics, Inc.'s price / book has grown at a 32.6% compound annual growth rate (CAGR), from 7.3× to 29.8×.
- What does price / book mean?
- Market capitalization at the quarter end divided by shareholders' equity. The premium (or discount) the market assigns to the company's book equity.
Ask your AI about Travere Therapeutics, Inc.'s price / book.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude